claim
Metformin is used to treat type II diabetic patients with dyslipidemia and low-grade inflammation, and it reduces circulating TNF-alpha, IL-1beta, CRP, and fibrinogen.
Authors
Sources
- Chronic Inflammation - StatPearls - NCBI Bookshelf www.ncbi.nlm.nih.gov via serper
Referenced by nodes (7)
- TNF-α concept
- inflammation concept
- chronic inflammation concept
- type 2 diabetes concept
- hyperlipidemia concept
- metformin concept
- CRP concept